doi: 10.1038/nri2763.
Therapeutic antibodies: past, present and future
- PMID: 20422787
- DOI: 10.1038/nri2763
Item in Clipboard
Therapeutic antibodies: past, present and future
Nat Rev Immunol.
2010 May.
Abstract
Over the past 10 years, the market for monoclonal antibodies has grown exponentially. This focus issue brings together articles on the basic biology of antibodies and their therapeutic use, providing an overview of the latest prospects and continued challenges for the development of safe, efficient and affordable therapeutic antibodies.
Similar articles
-
The therapeutic antibodies market to 2008.Eur J Pharm Biopharm. 2005 Apr;59(3):389-96. doi: 10.1016/j.ejpb.2004.11.007. Eur J Pharm Biopharm. 2005. PMID: 15760719
-
Guardians at the gate: patent protection for therapeutic monoclonal antibodies--part 1.MAbs. 2009 Jul-Aug;1(4):382-4. doi: 10.4161/mabs.1.4.8860. Epub 2009 Jul 25. MAbs. 2009. PMID: 20068400 Free PMC article.
-
The current status and prospects of antibody engineering for therapeutic use: focus on glycoengineering technology.J Pharm Sci. 2015 Mar;104(3):930-41. doi: 10.1002/jps.24316. Epub 2015 Jan 12. J Pharm Sci. 2015. PMID: 25583555 Review.
-
The therapeutic monoclonal antibody market.MAbs. 2015;7(1):9-14. doi: 10.4161/19420862.2015.989042. MAbs. 2015. PMID: 25529996 Free PMC article. Review.
-
[Monoclonal antibodies. Diagnostic and therapeutic use and prospects for the future].Rev Fr Transfus Hemobiol. 1993 Apr;36(2):149-77. doi: 10.1016/s1140-4639(05)80231-x. Rev Fr Transfus Hemobiol. 1993. PMID: 8503970 Review. French. No abstract available.
Cited by
-
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance.Nat Rev Clin Oncol. 2024 Nov;21(11):818-832. doi: 10.1038/s41571-024-00939-2. Epub 2024 Sep 13. Nat Rev Clin Oncol. 2024. PMID: 39271787 Review.
-
Biocatalytic Method for Producing an Affinity Resin for the Isolation of Immunoglobulins.Biomolecules. 2024 Jul 14;14(7):849. doi: 10.3390/biom14070849. Biomolecules. 2024. PMID: 39062563 Free PMC article.
-
Cancer drugs with high repositioning potential for Alzheimer's disease.Expert Opin Emerg Drugs. 2023 Dec;28(4):311-332. doi: 10.1080/14728214.2023.2296079. Epub 2023 Dec 26. Expert Opin Emerg Drugs. 2023. PMID: 38100555 Review.
-
Bispecific Antibody Detection Using Antigen-Conjugated Synthetic Nucleic Acid Strands.ACS Sens. 2023 Nov 24;8(11):4014-4019. doi: 10.1021/acssensors.3c01717. Epub 2023 Oct 19. ACS Sens. 2023. PMID: 37856082 Free PMC article.
-
Design and Construction of Antibody Fusion Proteins Incorporating Variable New Antigen Receptor (VNAR) Domains.Methods Mol Biol. 2024;2720:17-33. doi: 10.1007/978-1-0716-3469-1_2. Methods Mol Biol. 2024. PMID: 37775655
References
-
- Nat Biotechnol. 2009 Nov;27(11):987-93 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
